Skip to main content
logo
Algorae Pharmaceuticals Limited (ASX:1AI)
Australia flag Australia · Delayed Price · Currency is AUD
0.0100
+0.0005 (5.26%)
Oct 29, 2026, 3:59 PM AEDT

Algorae Pharmaceuticals Ratios and Metrics

Millions AUD. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Market Capitalization
20208172310
Market Cap Growth
20.16%140.08%-50.00%-27.90%127.61%49.95%
Enterprise Value
1618613206
Last Close Price
0.010.010.010.010.010.01

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
PS Ratio
-----3019.57
PB Ratio
4.764.753.795.606.222.55
P/TBV Ratio
4.764.753.795.606.222.55

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
EV/Sales Ratio
-----1723.99

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Net Debt / Equity Ratio
-0.92-0.92-1.04-1.03-1.09-1.05
Net Debt / EBITDA Ratio
---1.822.702.91
Net Debt / FCF Ratio
1.511.512.952.042.072.07
Asset Turnover
-----0.00
Quick Ratio
22.7522.7513.9017.669.3517.84
Current Ratio
25.1125.1114.1317.899.3517.84
Return on Equity (ROE)
-83.53%-83.53%-30.63%-61.85%-54.06%-72.33%
Return on Assets (ROA)
-41.93%-41.93%-23.85%-28.78%-22.41%-30.84%
Return on Capital Employed (ROCE)
-53.80%-53.80%-47.90%-56.60%-40.40%-36.20%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Earnings Yield
-15.27%-13.38%-9.52%-12.42%-9.01%-19.04%
FCF Yield
-12.84%-12.86%-9.31%-9.03%-8.49%-19.90%
Buyback Yield / Dilution
-5.15%-5.15%-1.46%-23.47%-53.82%-53.24%